STOCK TITAN

Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open-market trade

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Enovis CORP Chief Administrative Officer Oliver Engert bought 1,000 shares of common stock in an open-market purchase at a weighted average price of $23.93 per share. This increases his directly owned stake to 47,640 common shares.

The filing notes the purchase was executed through multiple trades within a price range from $23.75 to $24.10 per share. The transaction represents a relatively small addition compared with his total reported holdings, suggesting a routine increase in personal investment exposure to the company.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Engert Oliver

(Last) (First) (Middle)
2900 LAKE VISTA DRIVE
SUITE 200

(Street)
LEWISVILLE TX 75067

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Administrative Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/10/2026 P 1,000 A $23.93(1) 47,640 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $23.75 to $24.10, inclusive. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
/s/ Brian P. Hanigan, attorney-in-fact 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovis (ENOV) report for Oliver Engert?

Enovis reported that Chief Administrative Officer Oliver Engert bought 1,000 common shares. The shares were acquired in an open-market purchase at a weighted average price of $23.93, modestly increasing his directly held ownership position in the company.

At what price did Oliver Engert buy Enovis (ENOV) shares?

Oliver Engert bought Enovis common stock at a weighted average price of $23.93 per share. According to the filing, the shares were purchased in multiple trades, with individual transaction prices ranging from $23.75 to $24.10 per share.

How many Enovis (ENOV) shares does Oliver Engert hold after this transaction?

After the reported purchase, Oliver Engert directly holds 47,640 Enovis common shares. The 1,000-share open-market acquisition slightly increases his overall position, as disclosed in the insider ownership totals following the transaction.

Was the Enovis (ENOV) insider trade by Oliver Engert a buy or a sell?

The reported Enovis insider trade by Oliver Engert was a buy. The filing classifies the transaction as an open-market purchase of 1,000 common shares, adding to his existing directly owned stake in the company.

How was the purchase price for Oliver Engert’s Enovis (ENOV) shares calculated?

The reported $23.93 price is a weighted average across multiple trades. The filing explains that the 1,000 shares were acquired in separate transactions with prices between $23.75 and $24.10, resulting in the disclosed weighted average purchase price.
Enovis Corp

NYSE:ENOV

View ENOV Stock Overview

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.34B
55.92M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON